Effect of enteral diet enriched with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with sepsis-induced acute respiratory distress syndrome

Abstract

BackgroundIn this study, the effects of an enteral diet enriched with eicosapentaenoic acid (EPA), γ-linolenic acid (GLA), and antioxidants were compared with a standard enteral diet in critically ill patients with sepsis-induced acute respiratory distress syndrome (ARDS).MethodsThis study was a single-center, prospective, randomized, single-blind, controlled trial in our Advanced Critical Care Center. Patients were randomized to receive a continuous EPA, GLA, and antioxidant-enriched diet (study group), or an isocaloric standard diet (control group).ResultsTwenty-three of 46 patients were in the study group, and the other 23 were in the control group. Duration of mechanical ventilation, incidence of new nosocomial infections, changes over time in Sequential Organ Failure Assessment (SOFA) scores, and 60-day mortality were not significantly different between the two groups. The ratio of partial pressure of oxygen to fraction of inspired oxygen on day 7 was significantly higher in the study group (233.0 [185.5–282.8] vs. 274.0 [225.5–310.8], p = 0.021). Duration of ICU stay was significantly shorter in the study group than in the control group (24.0 [20.0–30.0] vs. 15.0 [11.0–24.0], p = 0.008).ConclusionsAn enteral diet enriched with EPA, GLA, and antioxidants did not improve duration of mechanical ventilation, SOFA score, incidence of new nosocomial infections, or mortality but did favorably influence duration of ICU stay in critically ill patients with sepsis-induced ARDS.Electronic supplementary materialThe online version of this article (doi:10.1186/s40560-015-0087-2) contains supplementary material, which is available to authorized users.

Omega-3 supplementation in patients with sepsis: a systematic review and meta-analysis of randomized trials

“…Three studies [31, 35, 37] required both sepsis and mechanical ventilation for inclusion. One study [32] enrolled ICU and post-anaesthesia care unit (PACU) patients with abdominal sepsis; we abstracted data for the ICU subset only.…”

“…Brand-name formulae used included Omegaven [29, 32–34, 38, 41], Oxepa [31, 36, 37], Impact [28, 30], and Lipoplus [43]. Available data on the contents of all brand-name intervention and control formulae are given in Additional file 1: Tables S4–S5.…”

“…For the mortality outcome, exclusion of trials in which ICU admission was unclear [39], trials published in abstract form [32], trials without explicit blinding of patients and healthcare personnel [25, 29–31, 33, 37, 39–43], and trials that did not administer the control group a placebo feed [25, 29, 33, 41] yielded similar non-significant results.…”

Value of Nutrition Support Therapy: Impact on Clinical and Economic Outcomes in the United States

“…To that end, the Medicare data mostly reflect patients who are older than 65 years, limiting the findings of this analysis to older adult patients in the Medicare program. In the example illustrated, the mean age of the patients ranged from 71 to 74 years . Finally, the documented presence of malnutrition was not available across all analyses, because the limited sample size in certain populations did not produce viable results.…”

Antioxidants as therapeutics in the intensive care unit: Have we ticked the redox boxes?

“…Some studies are in favor of the antioxidant treatments, others have demonstrated no effect, while the risk for adverse outcomes due to pro-oxidant phenomena has also been stressed [15,16,17]. Noteworthy, even the relevant reviews and meta-analyses did not result in a universally accepted takehome message [18,19,20,21].…”